Gyn Cancer Research News - #SGOmtg - #ASCO21

 

It is our pleasure to once again share with our community the latest gyn cancer research news from the SGO Annual Meeting (#SGOmtg) and the ASCO Annual Meeting (#ASCO21). SGO is the Society for Gynecologic Oncology and ASCO is the American Society of Clinical Oncology. Both of their annual meetings were once again held virtually due to the COVID-19 pandemic. 

On June 9, 2021 at 8pm ET (7pm CT, 5PM PT), we invite you to join us as we review some of the latest research and discussions related to gynecologic cancer screening, treatment and research.  We may touch upon secondary surgery, PARP inhibitors, immunotherapy, rare ovarian cancer treatments, early detection and trials with negative results. Each annual meeting has/had several sessions on disparities in the treatment of gyn cancer which we will include in our topic questions. 

We will use these topic questions to guide our discussion

T1: 

What #SGOMtg presentations did you personally find of most interest?

Anything practice-changing to note?

T2: 

There was a session at #SGOmtg entitled "Time to Return to the Drawing Board: Learning From Negative Trials." 

What are "negative" trials and what are some key take-aways?   

T3: 

Which #ASCO21 studies do you think may be of most interest to patients?

T4: 

What are some of the "hot topics" in gynecologic cancer research currently ( PARPs, cytoreductive surgery, immunotherapy, other)? What is still up for debate that patients/survivors/advocates should be aware of?

T5:

Are there recent studies surrounding palliative care, survivorship, and psychosocial research that could help gyn cancer survivors? 

T6: 

Both #ASCO21 and #SGOmtg held sessions on disparities in gynecologic cancer care. What was highlighted and how can we work to decrease disparities?

T7: 

For remaining time, please feel free to ask questions about or highlight other recent research you find of interest. What studies are on the horizon? What areas would you like to see more research?

We look forward to having you join us. 

Dee and Christina

Co-founders #gyncsm Twitter Community